Skip to main content
eScholarship
Open Access Publications from the University of California

HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.

  • Author(s): Ren, Shuling
  • Gaykalova, Daria A
  • Guo, Theresa
  • Favorov, Alexander V
  • Fertig, Elana J
  • Tamayo, Pablo
  • Callejas-Valera, Juan Luis
  • Allevato, Mike
  • Gilardi, Mara
  • Santos, Jessica
  • Fukusumi, Takahito
  • Sakai, Akihiro
  • Ando, Mizuo
  • Sadat, Sayed
  • Liu, Chao
  • Xu, Guorong
  • Fisch, Kathleen M
  • Wang, Zhiyong
  • Molinolo, Alfredo A
  • Gutkind, J Silvio
  • Ideker, Trey
  • Koch, Wayne M
  • Califano, Joseph A
  • et al.
Abstract

The dominant paradigm for HPV carcinogenesis includes integration into the host genome followed by expression of E6 and E7 (E6/E7). We explored an alternative carcinogenic pathway characterized by episomal E2, E4, and E5 (E2/E4/E5) expression. Half of HPV positive cervical and pharyngeal cancers comprised a subtype with increase in expression of E2/E4/E5, as well as association with lack of integration into the host genome. Models of the E2/E4/E5 carcinogenesis show p53 dependent enhanced proliferation in vitro, as well as increased susceptibility to induction of cancer in vivo. Whole genomic expression analysis of the E2/E4/E5 pharyngeal cancer subtype is defined by activation of the fibroblast growth factor receptor (FGFR) pathway and this subtype is susceptible to combination FGFR and mTOR inhibition, with implications for targeted therapy.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View